Advanced Inhalation Therapies raises $10m

Advanced Inhalation Therapies closed a $10.2 million offering yesterday. According to regulatory filings, 39 investors contributed to the offering, which made its 1st sale on Jan. 13.

The Israel-based company is developing a drug delivery device to treat severe respiratory infections and lung diseases using a high dose of nitric oxide.

The company plans to use $604,000 from the offering to compensate Ladenburg Thalmann & Co. Inc. for sales and $150,000 for executive officers, directors or promoters.

Get the full story at our sister site, Drug Delivery Business News.

The post Advanced Inhalation Therapies raises $10m appeared first on MassDevice.

from MassDevice http://ift.tt/2jZAARW